Search results
Results From The WOW.Com Content Network
A multimillion-pound legal battle between rival developers of Covid-19 jabs over vaccine technology patents is set to continue at the Court of Appeal.
A legal battle between rival developers of Covid-19 jabs over life-saving vaccine technology patents has produced a mixed ruling from a High Court judge.
(Reuters) -Moderna said on Friday the European Patent Office had upheld the validity of one of the company's key patents, a win in an ongoing COVID-19 vaccine dispute with Pfizer and BioNTech.
Pfizer, BioNTech and biotech firm Promosome told a federal judge in San Diego, California that they have agreed to end Promosome's lawsuit accusing the COVID-19 vaccine makers of infringing a ...
The High Court gave a mixed ruling in July, ruling that one of Moderna's two patents relating to the messenger RNA (mRNA) technology that underpinned its COVID-19 vaccine was invalid.
(Reuters) -Alnylam Pharmaceuticals said on Friday it plans to appeal a ruling by the U.S. District Court for the District of Delaware on two patents asserted against Moderna for the latter's COVID ...
US firm Moderna is suing its competitors for alleged patent infringement in relation to their Comirnaty vaccine. Moderna, Pfizer and BioNTech Covid vaccine patent dispute heads to 2024 trial Skip ...
Biotech firm Promosome LLC sued Moderna, Pfizer and BioNTech in federal court in San Diego, California, on Tuesday, accusing their COVID-19 vaccines of infringing a patent related to messenger RNA ...